Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Until two years ago, such discussion was of little practical relevance since there were few treatments for obesity between ...

Neoadjuvant semaglutide before metabolic and bariatric surgery is not beneficial in terms of weight loss, according to study findings.

Leading pharmaceutical companies, including Dr Reddy's, Sun Pharma, Cipla, Mankind Pharma, and Natco Pharma, among others, ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity medications compared to lifestyle modification alone. Results indicate that ...

A phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving with low-dose semaglutide. HealthDay News — Low-dose semaglutide seems to reduce craving and certain ...